HAVCR2 and neoplasm: In vitro, we found that Gal-9 preferentially induced death of primary T cells whereas leukemic T cells and other tumor cells, which do not express TIM-3, were considerably refractory to Gal-9-induced cell death (Supplementary Fig. 2g, h).